A plant biotechnology solution that uses a soybean-specific GRF4-GIF1 chimera system to dramatically improve transformation efficiency in tropical soybean cultivars. The approach addresses low transformation rates (~3%) and genotype limitations, enabling functional genomics and crop trait improvement in previously un-transformable elite soybean lines.
This research program develops a soybean-specific morphogenic regulator system to overcome one of the major bottlenecks in soybean biotechnology: low and genotype-restricted transformation efficiency. Current soybean transformation methods are limited to a few elite cultivars and achieve only about 3% efficiency, making functional genomics and trait improvement slow and costly. By deploying a GmGRF4-GmGIF1 chimera system tailored to soybean, the program aims to boost regeneration rates, shorten tissue culture timelines, and extend transformation capability to non-transformable tropical soybean lines. The work directly benefits soybean breeding programs, functional genomics studies, and agricultural biotechnology companies seeking reliable genetic modification in tropical germplasm.
The program is at an early-to-mid research stage (TRL 3-4). The laboratory has already established a working cotyledon cut-node transformation protocol for tropical soybean and has characterized the expression and conservation of GmGRF4 and GmGIF1. The next phase involves comparative validation of the citrus and soybean GRF-GIF systems against the conventional method on DT26, followed by application to two additional non-transformable elite lines. The research is expected to take approximately 1.5 years to complete. The team is actively seeking chemical reagents, equipment, and funding for key personnel to support this work.
Founded as Missouri’s flagship land‑grant, the University of Missouri–Columbia is a comprehensive public research university serving a large student body and partners statewide. Industry engages on campus through co‑located research cores, a research park and incubator in Columbia, and access to a high‑power university research reactor supporting isotope production and advanced testing. An integrated academic health system enables clinical studies and translation, while a statewide extension and agricultural research network links companies to field sites, producers, and community testbeds across Missouri. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated tech transfer office supports IP, licensing, and sponsored‑research agreements.